Cargando…

Molecular Modeling of Cardiac Sodium Channel with Mexiletine

A sodium channel blocker mexiletine (MEX) is used to treat chronic pain, myotonia and some arrhythmias. Mutations in the pore domain (PD) of voltage-gated sodium channels differently affect tonic block (TB) and use-dependent block (UDB) by MEX. Previous studies identified several MEX-sensing residue...

Descripción completa

Detalles Bibliográficos
Autor principal:	Zhorov, Boris S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786191/ https://www.ncbi.nlm.nih.gov/pubmed/36557159 http://dx.doi.org/10.3390/membranes12121252

Ejemplares similares

Pyrethroids in an AlphaFold2 Model of the Insect Sodium Channel
por: Zhorov, Boris S., et al.
Publicado: (2022)

Intersegment Contacts of Potentially Damaging Variants of Cardiac Sodium Channel
por: Korkosh, Vyacheslav S., et al.
Publicado: (2021)

Molecular Insights into the Local Anesthetic Receptor within Voltage-Gated Sodium Channels Using Hydroxylated Analogs of Mexiletine
por: Desaphy, Jean-François, et al.
Publicado: (2012)

The Effect of Sodium Channel Blocker, Mexiletine, on Body Weight in Type 2 Diabetes Patients with Visceral Obesity
por: Ueno, Naohiko
Publicado: (2019)

Mechanism of sodium channel block by local anesthetics, antiarrhythmics, and anticonvulsants
por: Tikhonov, Denis B., et al.
Publicado: (2017)

Sodium Channel Mutations and Pyrethroid Resistance in Aedes aegypti
por: Du, Yuzhe, et al.
Publicado: (2016)

Predicting Structural Details of the Sodium Channel Pore Basing on Animal Toxin Studies
por: Tikhonov, Denis B., et al.
Publicado: (2018)

Possible Interactions of Extracellular Loop IVP2-S6 With Voltage-Sensing Domain III in Cardiac Sodium Channel
por: Zaytseva, Anastasia K., et al.
Publicado: (2021)

Gating Properties of Mutant Sodium Channels and Responses to Sodium Current Inhibitors Predict Mexiletine-Sensitive Mutations of Long QT Syndrome 3
por: Li, Gang, et al.
Publicado: (2020)

Molecular evidence of sequential evolution of DDT- and pyrethroid-resistant sodium channel in Aedes aegypti
por: Chen, Mengli, et al.
Publicado: (2019)

Allosteric interactions among voltage-sensor modules of sodium channels probed by scorpion toxin modifiers
por: Gurevitz, Michael, et al.
Publicado: (2022)

Calixmexitil: Calixarene-based Cluster of Mexiletine with Amplified Anti-myotonic Activity as A Novel Use-dependent Sodium Channel Blocker
por: Delnavaz Shahr, Amirali, et al.
Publicado: (2019)

A patient with mexiletine-related psychosis
por: Shailesh, Fnu, et al.
Publicado: (2011)

Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients
por: Hu, Rou-Mu, et al.
Publicado: (2018)

Folding similarity of the outer pore region in prokaryotic and eukaryotic sodium channels revealed by docking of conotoxins GIIIA, PIIIA, and KIIIA in a NavAb-based model of Nav1.4
por: Korkosh, Viacheslav S., et al.
Publicado: (2014)

Selectivity filters and cysteine-rich extracellular loops in voltage-gated sodium, calcium, and NALCN channels
por: Stephens, Robert F., et al.
Publicado: (2015)

Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F Na(V)1.7 sodium channels
por: Cregg, R, et al.
Publicado: (2014)

Dual Action of Mexiletine and Its Pyrroline Derivatives as Skeletal Muscle Sodium Channel Blockers and Anti-oxidant Compounds: Toward Novel Therapeutic Potential
por: De Bellis, Michela, et al.
Publicado: (2018)

Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine
por: Gualdani, Roberta, et al.
Publicado: (2015)

Experience with oral mexiletine in primary erythromelalgia in children
por: Iqbal, Javeed, et al.
Publicado: (2009)

A homology model of the pore domain of a voltage-gated calcium channel is consistent with available SCAM data
por: Bruhova, Iva, et al.
Publicado: (2010)

P-Loop Channels: Experimental Structures, and Physics-Based and Neural Networks-Based Models
por: Tikhonov, Denis B., et al.
Publicado: (2022)

Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation
por: Liu, Guizhi, et al.
Publicado: (2017)

A lysine residue from an extracellular turret switches the ion preference in a Cav3 T-Type channel from calcium to sodium ions
por: Guan, Wendy, et al.
Publicado: (2022)

Computational Analysis of the Crystal and Cryo-EM Structures of P-Loop Channels with Drugs
por: Tikhonov, Denis B., et al.
Publicado: (2021)

Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial
por: Yamada, Shinichiro, et al.
Publicado: (2022)

Therapeutic drug monitoring of mexiletine at a large academic medical center
por: Nei, Scott D, et al.
Publicado: (2016)

Monte Carlo-energy minimization of correolide in the Kv1.3 channel: possible role of potassium ion in ligand-receptor interactions
por: Bruhova, Iva, et al.
Publicado: (2007)

Batrachotoxin acts as a stent to hold open homotetrameric prokaryotic voltage-gated sodium channels
por: Finol-Urdaneta, Rocio K., et al.
Publicado: (2019)

Management of ventricular tachycardia--role of mexiletine : proceedings of a symposium held in Copenhagen, Denmark, 25th-27th May, 1978 /
Publicado: (1978)

Case report: Mexiletine suppresses ventricular arrhythmias in Andersen-Tawil syndrome
por: Yang, Jing, et al.
Publicado: (2022)

A Case of Mexiletine-induced Hypersensitivity Syndrome Presenting as Eosinophilic Pneumonia
por: Lee, Sang-Pyo, et al.
Publicado: (2010)

Extremely Potent Block of Bacterial Voltage-Gated Sodium Channels by µ-Conotoxin PIIIA
por: Finol-Urdaneta, Rocio K., et al.
Publicado: (2019)

Mexiletine-like cellular electrophysiological effects of GS967 in canine ventricular myocardium
por: Hézső, Tamás, et al.
Publicado: (2021)

Verification of the Efficacy of Mexiletine Treatment for the A1656D Mutation on Downgrading Reentrant Tachycardia Using a 3D Cardiac Electrophysiological Model
por: Qauli, Ali Ikhsanul, et al.
Publicado: (2022)

Designer Gelators for the Crystallization of a Salt Active Pharmaceutical Ingredient—Mexiletine Hydrochloride
por: Andrews, Jessica L., et al.
Publicado: (2022)

Voltage-Dependent Inhibition of Glycine Receptor Channels by Niflumic Acid
por: Maleeva, Galyna, et al.
Publicado: (2017)

Mexiletine Differentially Restores the Trafficking Defects Caused by Two Brugada Syndrome Mutations
por: Moreau, Adrien, et al.
Publicado: (2012)

Mexiletine Treatment for Neonatal LQT3 Syndrome: Case Report and Literature Review
por: Bagkaki, Alena, et al.
Publicado: (2021)

Mexiletine and False Positive Urine Drug Screen for Amphetamine: A Case Review
por: Sohal, Sumit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6lnm01r4r6ae3l4jooilfvr7j0